We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 5,784

State Attorneys General Warn the EPA of Legal Action Should Obama-Era Fuel Economy Standards Get Rolled Back
  • Foley & Lardner LLP
  • USA
  • June 15 2017

Even as the Trump administration is calling into question whether it will remain committed to Obama-era fuel economy and emissions targets, state


Florida’s New Medical Marijuana Law and Telemedicine Exams
  • Foley & Lardner LLP
  • USA
  • June 14 2017

Following a special session, the Florida Legislature on June 9, 2017 passed two important bills regarding medical marijuana in the Sunshine State: SB


Supreme Court Biosimilar Patent Dance Decision Largely Favors Biosimilars
  • Foley & Lardner LLP
  • USA
  • June 13 2017

On June 12, 2017, the Supreme Court issued a unanimous decision in Sandoz Inc. v. Amgen Inc. (No. 15-1039), deciding that 42 U.S.C. 262(l)(9)(C


Trump Department of Labor Continues to Chip Away at Obama Wage & Hour Efforts - WHD Interpretive Guidance on Joint Employer and Independent Contractors Withdrawn
  • Foley & Lardner LLP
  • USA
  • June 12 2017

On Wednesday, June 7th, the U.S. Department of Labor (DOL) withdrew two highly provocative interpretive guidance letters issued under President


Practical Tips for Maintaining Dignity during Termination Meetings: Everybody Wins
  • Foley & Lardner LLP
  • USA
  • June 12 2017

This past week, the nation was shocked with yet another senseless act of violence in the workplace. On Monday, a disgruntled former employee, walked


Industry Perspectives On The Biosimilar Patent Dance
  • Foley & Lardner LLP
  • USA
  • June 12 2017

The Supreme Court could issue its decision in the Amgen v. Sandoz biosimilar patent dance case any day now. Last week I participated in a panel


Utilizing California Civil Code Section 1542 Waivers in Class Action Settlement Agreements: Helpful or Harmful?
  • Foley & Lardner LLP
  • USA
  • June 12 2017

A significant concern for any lawyer negotiating the settlement of a class action in California state court is crafting a settlement agreement that


Supreme Court Decision Largely Favors Biosimilar Applicants
  • Foley & Lardner LLP
  • USA
  • June 12 2017

The U.S. Supreme Court rendered its first interpretations of the biosimilar patent dispute resolution procedures of the Biologics Price Competition


Cities Plan for Future of Autonomous Cars
  • Foley & Lardner LLP
  • USA
  • June 12 2017

One year ago, we posted about the National Association of City Officials’s (NACTO) policy recommendations for autonomous vehicles. NACTO focused on


NIH Begins Beta Test of Million Patient Cohort
  • Foley & Lardner LLP
  • USA
  • June 10 2017

The National Institutes of Health announced the enrollment of the first participants as beta testers of the “All of Us” research program. Initially